Industry participants are working to create novel drugs for the treatment of seizures. During the course of the projected period, this is anticipated to fuel market expansion for benzodiazepine medications. For instance, in September 2021, Neurelis, Inc., a neuroscience business focused on innovation, launched a clinical programme to examine the use of VALTOCO (diazepam nasal spray) as a seizure cluster treatment in children with epilepsy, aged two to five. The study is currently in the clinical trial's Phase I/II. By December 2022, the study is anticipated to be done. Over the course of the projection period, product approvals by regulatory agencies are anticipated to fuel market expansion for benzodiazepine medications.
The global Benzodiazepine Drugs Market is estimated to be valued at US$ 3,050.4 Mn in 2022 and is expected to exhibit a CAGR of 3.2% over the forecast period (2022-2030)
Market Leaders in the Benzodiazepine Drugs Industry:
1. F. Hoffmann-La Roche Ltd.
Roche Holding AG engages in the pharmaceuticals and diagnostics. The company was founded in 1896 and is headquartered in Basel, Switzerland.
2. Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. The company was founded in 1959 and is based in Ahmedabad, India.
3. Mallinckrodt Pharmaceuticals
Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company was founded in 1867 and is based in Dublin, Ireland.
4. Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. on December 2022, Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial, early and deep responses, and a manageable safety profile for elranatamab in heavily pretreated patients with advanced multiple myeloma.
5. Bausch Health Companies Inc
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. It was founded in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada. On Aug. 10, 2022 Bausch Health Companies Inc. and its gastroenterology business, Salix Pharmaceuticals, announced its support of the publication of a new specific ICD-10 code from the Centers for Medicare & Medicaid Services (CMS) for hepatic encephalopathy (HE) based on the growing incidence of chronic liver disease in the United States.
6. Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
7. Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals LLC was founded in 2002 and since then developes, licenses, manufactures, markets and distributes generic and speciality pharmaceutical products. The company headquarters are situated in Bridgewater, New Jersey. Amneal Pharmaceuticals LLC in November, 2022 announced the commercial launch of RELEUKO a biosimilar referencing Neupogen RELEUKO used to treat neutropenia.
8. Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company was founded in 1983 and is based in Mumbai, India.
9. Aurobindo Pharma Ltd.
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.
*Definition- Anxiety, sleeplessness, seizures, social phobia, and panic disorder can all be treated with benzodiazepines, a class of medications.
